Fears that GLP-1 obesity drugs would reduce demand for ResMed’s various CPAP airflow machines have proven unfounded..

The application of CPAP devices is considered as a backbone for people who have sleep apnea. These devices keep airways open ...

ResMed (NYSE: RMD, ASX: RMD), the world’s leading health technology company focused on sleep, breathing, and care delivered in the home, today ...

“New commercial excellence and demand generation initiatives will drive more patients into ResMed’s funnel, where they will be served by a robust road map of new products, such as the AirTouch N30i ...

The Resmed CDI (ASX:RMD) share price is up 38.6% since the start of 2024. It's probably worth asking, 'is the RMD share price ...

such as the AirTouch N30i next-generation CPAP mask unveiled earlier today. Capitalize on ResMed’s market opportunity and brand advantage in broader sleep health and breathing health adjacencies ...

ResMed chief executive Mick Farrell ... such as the AirTouch N30i next-generation CPAP mask.” The company said it would also seek to broaden its sleep health and breathing health offerings ...

Learn More ResMed (ASX: RMD) shares are outperforming the market on Tuesday. In afternoon trade, the sleep disorder treatment company's shares are up 2% to $35.73. This compares favourably to a 0. ...

Pottery Barn took on the challenge of housing a CPAP machine used to treat Obstructive ... with the condition can use to conceal those pesky masks, cords and hoses while still keeping them within ...

Valued at $35.3 billion by market cap, San Diego, California-based ResMed Inc. (RMD) develops, manufactures, distributes, and markets medical devices and cloud-based software applications for ...

Since its inception in 2009, Air Voel has been a pioneer in helping Canadians manage their sleep apnea effectively. As a leading online provider of CPAP supplies, Air Voel has established itself as a ...